1. Promyelocytic Leukemia protein (PML) interacts with ASC to limit Inflammasome Activation.
Dowling JK, Becker CE, Bourke NM, Corr SC, Connolly DJ, Quinn SR, Pandolfi PP, Mansell A, O'Neill LA.
J Biol Chem. 2014 Jan 9. [Epub ahead of print]
PMID: 24407287 [PubMed - as supplied by publisher] Free Article
2. Of model pets and cancer models: an introduction to mouse models of cancer.
Lunardi A, Nardella C, Clohessy JG, Pandolfi PP.
Cold Spring Harb Protoc. 2014 Jan 1;2014(1). pii: pdb.top069757. doi: 10.1101/pdb.top069757.
PMID: 24371312 [PubMed - in process]
3. Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia.
Dos Santos GA, Kats L, Pandolfi PP.
J Exp Med. 2013 Dec 16;210(13):2793-802. doi: 10.1084/jem.20131121.
PMID: 24344243 [PubMed - in process]
4. Utility of LRF/Pokemon and NOTCH1 Protein Expression in the Distinction of Nodular Lymphocyte-Predominant Hodgkin Lymphoma and Classical Hodgkin Lymphoma.
Bohn O, Maeda T, Filatov A, Lunardi A, Pandolfi PP, Teruya-Feldstein J.
Int J Surg Pathol. 2013 Dec 10. [Epub ahead of print]
PMID: 24326827 [PubMed - as supplied by publisher]
5. BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP.
Morotti A, Panuzzo C, Crivellaro S, Pergolizzi B, Familiari U, Berger AH, Saglio G, Pandolfi PP.
Leukemia. 2013 Dec 9. doi: 10.1038/leu.2013.370. [Epub ahead of print]
PMID: 24317448 [PubMed - as supplied by publisher]